Abiopharma

🔍 Kelly Peter J (Director)

Company: OPENLANE, Inc. (OPLN)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 14,830 shares of Common Stock at $33.715 per share (Direct)
  Date: 2026-08-24 | Code: P | equity_swap_involved: 0 | shares_owned_after: 14,830.15 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.6990 to $33.7200 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.